Glycyrrhetinic acid-mediated nanoparticles of hepatic targeted drug delivery system, process for preparing the same and use thereof
US9173852B2 · kind B2 · utility
0Cited by
2References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 18, 2008 |
| Grant date | Nov 3, 2015 |
| Priority date | — |
| Expiry date | Jul 3, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/906
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are a hepatic targeted drug delivery system and a process for preparing the same. Also disclosed is a method for treating liver cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.